Your browser doesn't support javascript.
loading
Superior renoprotective effects of the combination of breviscapine with enalapril and its mechanism in diabetic rats.
Xu, Xing-Xin; Zhang, Wei; Zhang, Pei; Qi, Xiang-Ming; Wu, Yong-Gui; Shen, Ji-Jia.
Afiliación
  • Xu XX; Department of Nephrology, The First Affiliated Hospital, Anhui Medical University, Hefei, Anhui, PR China.
Phytomedicine ; 20(10): 820-7, 2013 Jul 15.
Article en En | MEDLINE | ID: mdl-23664882
ABSTRACT
Breviscapine is a flavonoid extracted from a Chinese herb Erigeron breviscapus, previously it was shown that treatment with breviscapine attenuated renal injury in the diabetic rats. The purpose of this study was to investigate whether breviscapine combined with enalapril (an ACE inhibitor) have superior renoprotective effects against diabetic nephropathy. Rats were randomly separated into five groups control, diabetes, diabetes treated with enalapril, diabetes treated with breviscapine, or diabetes treated with combined enalapril with breviscapine. Twenty-four hours urinary AER and the levels of 3-NT in renal tissue and MDA in renal tissue and urine as well as activities and expression of PKC in renal tissue were determined, and renal tissue morphology were observed by light microscopy after 8 weeks. Expression of TGFß1 protein was performed by immunohistochemistry method. Increased AER and kidney pathologic injury were attenuated by treatment with either enalapril or breviscapine and further reduced by the combination of the two. Elevated 3-NT in renal tissue and MDA levels in renal tissue and urine were reduced by enalapril or breviscapine and, more effectively, by combined enalapril with breviscapine. PKC activities and expression were higher in renal tissue in diabetic rats than those of the control group, which were reduced by both monotherapies, and further abrogated by combination therapy in both cases. Overexpression of TGFß1 protein observed in the glomeruli and tubulointerstitium of diabetic rats was attenuated by enalapril or breviscapine to a similar lever and further reduced by the combination of the two. The combination of enalapril and breviscapine confers superiority over monotherapies on renoprotection, which mechanism may be at least partly correlated with synergetic suppression on increased oxidative stress and PKC activities as well as overexpression of TGFß1 in renal tissue.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Flavonoides / Inhibidores de la Enzima Convertidora de Angiotensina / Enalapril / Nefropatías Diabéticas / Riñón Tipo de estudio: Etiology_studies Idioma: En Revista: Phytomedicine Asunto de la revista: TERAPIAS COMPLEMENTARES Año: 2013 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Flavonoides / Inhibidores de la Enzima Convertidora de Angiotensina / Enalapril / Nefropatías Diabéticas / Riñón Tipo de estudio: Etiology_studies Idioma: En Revista: Phytomedicine Asunto de la revista: TERAPIAS COMPLEMENTARES Año: 2013 Tipo del documento: Article